171 related articles for article (PubMed ID: 30961950)
1. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
[TBL] [Abstract][Full Text] [Related]
2. Natural history of
Hwang JA; Kim S; Jo KW; Shim TS
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275170
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
[TBL] [Abstract][Full Text] [Related]
4. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.
Pan SW; Shu CC; Feng JY; Wang JY; Chan YJ; Yu CJ; Su WJ
Clin Infect Dis; 2017 Sep; 65(6):927-934. PubMed ID: 28541556
[TBL] [Abstract][Full Text] [Related]
5. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
[TBL] [Abstract][Full Text] [Related]
7. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
8. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Mycobacterium avium Complex (MAC).
Griffith DE
Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
[No Abstract] [Full Text] [Related]
10. Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.
Griffith DE; Adjemian J; Brown-Elliott BA; Philley JV; Prevots DR; Gaston C; Olivier KN; Wallace RJ
Am J Respir Crit Care Med; 2015 Sep; 192(6):754-60. PubMed ID: 26068042
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease.
Kim SJ; Park J; Lee H; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2014 Jun; 18(6):730-6. PubMed ID: 24903946
[TBL] [Abstract][Full Text] [Related]
12. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.
Min J; Park J; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1239-45. PubMed ID: 26459540
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
[TBL] [Abstract][Full Text] [Related]
14. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
[TBL] [Abstract][Full Text] [Related]
15. Association Between Duration of Aminoglycoside Treatment and Outcome of Cavitary Mycobacterium avium Complex Lung Disease.
Kim OH; Kwon BS; Han M; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
Clin Infect Dis; 2019 May; 68(11):1870-1876. PubMed ID: 30239615
[TBL] [Abstract][Full Text] [Related]
16. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
[TBL] [Abstract][Full Text] [Related]
17. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
[TBL] [Abstract][Full Text] [Related]
19. Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
Kitada S; Uenami T; Yoshimura K; Tateishi Y; Miki K; Miki M; Hashimoto H; Fujikawa T; Mori M; Matsuura K; Kuroyama M; Maekura R
Int J Tuberc Lung Dis; 2012 May; 16(5):660-4. PubMed ID: 22410245
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use.
Kim SM; Chong YP; Lee HJ; Shim TS; Jo KW
Microbiol Spectr; 2023 Jun; 11(3):e0474122. PubMed ID: 37022189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]